Human medicines European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva, efavirenz / emtricitabine / tenofovir disoproxil, HIV Infections, Date of authorisation: 17/07/2017, Revision: 4, Status: Authorised

Case Medical Research ◽

10.31525/cmr-399685 ◽

2019 ◽

Author(s):

Keyword(s):

Hiv Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Epivir, lamivudine, HIV Infections, Date of authorisation: 08/08/1996, Revision: 42, Status: Authorised

Case Medical Research ◽

10.31525/cmr-4d6de7 ◽

2019 ◽

Author(s):

Keyword(s):

Hiv Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Viread, tenofovir disoproxil, Hepatitis B, Chronic,HIV Infections, Date of authorisation: 04/02/2002, Revision: 51, Status: Authorised

Case Medical Research ◽

10.31525/cmr-39964c ◽

2019 ◽

Author(s):

Keyword(s):

Hepatitis B ◽

Hiv Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Atazanavir Mylan, atazanavir, HIV Infections, Date of authorisation: 22/08/2016, Revision: 6, Status: Authorised

Case Medical Research ◽

10.31525/cmr-3996e1 ◽

2019 ◽

Author(s):

Keyword(s):

Hiv Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Trogarzo, ibalizumab, HIV Infections, Date of authorisation: 26/09/2019, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1ee8d0e ◽

2019 ◽

Author(s):

Keyword(s):

Hiv Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Pifeltro, doravirine, HIV Infections, Date of authorisation: 22/11/2018, Revision: 2, Status: Authorised

Case Medical Research ◽

10.31525/cmr-863653 ◽

2019 ◽

Author(s):

Keyword(s):

Hiv Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Darunavir Mylan, darunavir, HIV Infections, Date of authorisation: 03/01/2017, Revision: 3, Status: Authorised

Case Medical Research ◽

10.31525/cmr-84cfd8 ◽

2019 ◽

Author(s):

Keyword(s):

Hiv Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Darunavir Krka, darunavir, HIV Infections, Date of authorisation: 26/01/2018, Revision: 3, Status: Authorised

Case Medical Research ◽

10.31525/cmr-84cfd7 ◽

2019 ◽

Author(s):

Keyword(s):

Hiv Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Efavirenz Teva, efavirenz, HIV Infections, Date of authorisation: 09/01/2012, Revision: 8, Status: Authorised

Case Medical Research ◽

10.31525/cmr-95e8eb ◽

2019 ◽

Author(s):

Keyword(s):

Hiv Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Combivir, lamivudine / zidovudine, HIV Infections, Date of authorisation: 18/03/1998, Revision: 29, Status: Authorised

Case Medical Research ◽

10.31525/cmr-8789ed ◽

2019 ◽

Author(s):

Keyword(s):

Hiv Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Zerit, stavudine, HIV Infections, Date of authorisation: 08/05/1996, Revision: 31, Status: Authorised

Case Medical Research ◽

10.31525/cmr-ea2d1b ◽

2019 ◽

Author(s):

Keyword(s):

Hiv Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text